Observational Study on Unhealthy Eating Behavior and the Effect of Sodium-Glucose Cotransporter 2 Inhibitors: The Luseogliflozin Ehime Diabetes Study

INTRODUCTION: Luseogliflozin is a sodium-glucose cotransporter 2 (SGLT2) inhibitor. Unhealthy eating behavior is associated with diabetes, hypertension, and obesity. However, evidence regarding the effect of medications, including SGLT2 inhibitors, on unhealthy eating behavior is limited. This study...

Descripción completa

Detalles Bibliográficos
Autores principales: Furukawa, Shinya, Miyake, Teruki, Miyaoka, Hiroaki, Matsuura, Bunzo, Hiasa, Yoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076764/
https://www.ncbi.nlm.nih.gov/pubmed/35426601
http://dx.doi.org/10.1007/s13300-022-01261-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9076764/
https://www.ncbi.nlm.nih.gov/pubmed/35426601
http://dx.doi.org/10.1007/s13300-022-01261-9

Ejemplares similares